209 related articles for article (PubMed ID: 24628410)
1. Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.
Pelligand L; King JN; Hormazabal V; Toutain PL; Elliott J; Lees P
J Vet Pharmacol Ther; 2014 Aug; 37(4):354-66. PubMed ID: 24628410
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation.
Pelligand L; King JN; Toutain PL; Elliott J; Lees P
J Vet Pharmacol Ther; 2012 Feb; 35(1):19-32. PubMed ID: 21767277
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.
King JN; Dawson J; Esser RE; Fujimoto R; Kimble EF; Maniara W; Marshall PJ; O'Byrne L; Quadros E; Toutain PL; Lees P
J Vet Pharmacol Ther; 2009 Feb; 32(1):1-17. PubMed ID: 19161451
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.
Landoni MF; Lees P
Equine Vet J; 1995 Jul; 27(4):247-56. PubMed ID: 8536660
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves.
Landoni MF; Lees P
Chirality; 1995; 7(8):586-97. PubMed ID: 8593252
[TBL] [Abstract][Full Text] [Related]
6. Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney.
Pelligand L; Suemanotham N; King JN; Seewald W; Syme H; Smith K; Lees P; Elliott J
BMC Vet Res; 2015 Dec; 11():296. PubMed ID: 26634699
[TBL] [Abstract][Full Text] [Related]
7. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
King JN; Jung M; Maurer MP; Schmid VB; Seewald W; Lees P
Am J Vet Res; 2013 Mar; 74(3):465-72. PubMed ID: 23438125
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling.
Landoni MF; Cunningham FM; Lees P
J Vet Pharmacol Ther; 1995 Oct; 18(5):315-24. PubMed ID: 8587147
[TBL] [Abstract][Full Text] [Related]
9. In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study.
Schmid VB; Seewald W; Lees P; King JN
J Vet Pharmacol Ther; 2010 Oct; 33(5):444-52. PubMed ID: 20840388
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat.
Arifah AK; Landoni MF; Lees P
J Vet Pharmacol Ther; 2003 Apr; 26(2):139-50. PubMed ID: 12667184
[TBL] [Abstract][Full Text] [Related]
11. Safety of oral robenacoxib in the cat.
King JN; Hotz R; Reagan EL; Roth DR; Seewald W; Lees P
J Vet Pharmacol Ther; 2012 Jun; 35(3):290-300. PubMed ID: 21736587
[TBL] [Abstract][Full Text] [Related]
12. Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib.
Giraudel JM; King JN; Jeunesse EC; Lees P; Toutain PL
J Vet Pharmacol Ther; 2009 Feb; 32(1):18-30. PubMed ID: 19161452
[TBL] [Abstract][Full Text] [Related]
13. Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats.
Heit MC; Stallons LJ; Seewald W; Thompson CM; Toutain CE; King SB; Helbig R
BMC Vet Res; 2020 Sep; 16(1):355. PubMed ID: 32988403
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.
Lees P; Toutain PL; Elliott J; Giraudel JM; Pelligand L; King JN
J Vet Pharmacol Ther; 2022 Jul; 45(4):325-351. PubMed ID: 35460083
[TBL] [Abstract][Full Text] [Related]
15. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.
Schmid VB; Spreng DE; Seewald W; Jung M; Lees P; King JN
J Vet Pharmacol Ther; 2010 Apr; 33(2):118-31. PubMed ID: 20444036
[TBL] [Abstract][Full Text] [Related]
16. Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.
King JN; Arnaud JP; Goldenthal EI; Gruet P; Jung M; Seewald W; Lees P
J Vet Pharmacol Ther; 2011 Jun; 34(3):298-311. PubMed ID: 21492194
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.
Giraudel JM; Toutain PL; King JN; Lees P
J Vet Pharmacol Ther; 2009 Feb; 32(1):31-40. PubMed ID: 19161453
[TBL] [Abstract][Full Text] [Related]
18. Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs.
Toutain CE; Heit MC; King SB; Helbig R
BMC Vet Res; 2017 Nov; 13(1):359. PubMed ID: 29179750
[TBL] [Abstract][Full Text] [Related]
19. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
King JN; Rudaz C; Borer L; Jung M; Seewald W; Lees P
Res Vet Sci; 2010 Jun; 88(3):497-506. PubMed ID: 20004922
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in the horse.
Landoni MF; Lees P
J Vet Pharmacol Ther; 1996 Dec; 19(6):466-74. PubMed ID: 8971676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
